Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

• Príomhchruthaitheoirí: Yongji Wang (Údar), Yangyang Qi (Údar), Wenguo Xu (Údar), Yuansheng Hu (Údar), Ling Wang (Údar), Yongpei Yu (Údar), Zhiwei Jiang (Údar), Jielai Xia (Údar), Gang Zeng (Údar), Yalong Wang (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Taylor & Francis Group, 2020-10-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, randomized, open-label clinical trial was performed...